Search
for
Sort by
Research 451–480 of 1000+
- Pramipexole
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- Hair disorders update: Alopecia to hirsutism
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- The dose‐response of percutaneous oestradiol implants on the skeletons of postmenopausal women
- A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
- Expert Medical Testimony
- Therapeutic Approach to Vaccine-Induced Ischemic Dermatopathy in a Pomeranian Dog with Refractory Alopecia
- Androgenisierung
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Pharmacology of anabolic steroids
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Treatment of Hair Loss
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Severe cutaneous adverse reactions to drugs
- Polycystic Ovary Syndrome
- Bioavailability of Albumin-Bound Testosterone†
- Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair
- Transforming growth factor-β in stem cells and tissue homeostasis
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Female pattern hair loss
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Telogen Effluvium
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- The PDGF/PDGFR pathway as a drug target
- Cutaneous signs in COVID ‐19 patients: A review